The sBLA is based on a Phase 3, randomized, double-blind, placebo-controlled, multicenter 184 subject trial. The sBLA submission was supported by findings from a Phase 3 multicenter, randomized, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback